Cargando…

Exploring brain glucose metabolic patterns in cognitively normal adults at risk of Alzheimer’s disease: A cross-validation study with Chinese and ADNI cohorts

OBJECTIVE: Disease-related metabolic brain patterns have been verified for a variety of neurodegenerative diseases including Alzheimer’s disease (AD). This study aimed to explore and validate the pattern derived from cognitively normal controls (NCs) in the Alzheimer’s continuum. METHODS: This study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Tao-Ran, Dong, Qiu-Yue, Jiang, Xue-Yan, Kang, Gui-Xia, Li, Xin, Xie, Yun-Yan, Jiang, Jie-Hui, Han, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648808/ https://www.ncbi.nlm.nih.gov/pubmed/34864286 http://dx.doi.org/10.1016/j.nicl.2021.102900

Ejemplares similares

Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort
por: Zainul Abidin, Fatin N., et al.
Publicado: (2021)

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition
por: Toledo, Jon B, et al.
Publicado: (2014)

Systematic comparison of different techniques to measure hippocampal subfield volumes in ADNI2
por: Mueller, Susanne G., et al.
Publicado: (2017)

Genomic Copy Number Analysis in Alzheimer's Disease and Mild Cognitive Impairment: An ADNI Study
por: Swaminathan, Shanker, et al.
Publicado: (2011)

Evaluating trajectories of episodic memory in normal cognition and mild cognitive impairment: Results from ADNI
por: Ding, Xiuhua, et al.
Publicado: (2019)

Bayesian estimation for the accuracy of three neuropsychological tests in detecting Alzheimer's disease and mild cognitive impairment: a retrospective analysis of the ADNI database
por: Wang, Xiaonan, et al.
Publicado: (2023)

Development and validation of language and visuospatial composite scores in ADNI
por: Choi, Seo‐Eun, et al.
Publicado: (2020)

The Worldwide Alzheimer's Disease Neuroimaging Initiative: ADNI‐3 updates and global perspectives
por: Weber, Christopher J., et al.
Publicado: (2021)

Cognitive dedifferentiation as a function of cognitive impairment in the ADNI and MemClin cohorts
por: Wallert, John, et al.
Publicado: (2021)

Clusters of male and female Alzheimer’s disease patients in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
por: Gamberger, Dragan, et al.
Publicado: (2016)

Network-based analysis of genetic variants associated with hippocampal volume in Alzheimer’s disease: a study of ADNI cohorts
por: Song, Ailin, et al.
Publicado: (2016)

β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer’s disease and predicts cerebral amyloidosis
por: Li, Tao-Ran, et al.
Publicado: (2022)

A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols
por: Brunton, Simon, et al.
Publicado: (2015)

An Alzheimer’s disease category progression sub-grouping analysis using manifold learning on ADNI
por: van der Haar, Dustin, et al.
Publicado: (2023)

Using imputation to provide harmonized longitudinal measures of cognition across AIBL and ADNI
por: Shishegar, Rosita, et al.
Publicado: (2021)

Comparison of [(18)F]Flutemetamol and [(11)C]Pittsburgh Compound-B in cognitively normal young, cognitively normal elderly, and Alzheimer's disease dementia individuals
por: Lowe, Val J., et al.
Publicado: (2017)

Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer’s disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort
por: Fan, Lei, et al.
Publicado: (2023)

Imago Mundi, Imago AD, Imago ADNI
por: Villemagne, Victor L, et al.
Publicado: (2014)

A Novel Deep Learning Radiomics Model to Discriminate AD, MCI and NC: An Exploratory Study Based on Tau PET Scans from ADNI †
por: Zhao, Yan, et al.
Publicado: (2022)

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
por: Ben Bouallègue, Fayçal, et al.
Publicado: (2017)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
por: Ismail, Zahinoor, et al.
Publicado: (2023)

Local Atrophy Observed in Subjective Cognitive Decline Varies Based on Questionnaire Employed in ADNI
por: Morrison, Cassandra, et al.
Publicado: (2021)

Multivariate Protein Signatures of Pre-Clinical Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) Plasma Proteome Dataset
por: Johnstone, Daniel, et al.
Publicado: (2012)

Sample Size Estimation for Alzheimer’s Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging
por: Fujishima, Motonobu, et al.
Publicado: (2017)

Pairwise Correlation Analysis of the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Dataset Reveals Significant Feature Correlation
por: Huckvale, Erik D., et al.
Publicado: (2021)

Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease
por: Vasanthakumar, Aparna, et al.
Publicado: (2020)

Clinical and multimodal biomarker correlates of ADNI neuropathological findings
por: Toledo, Jon B, et al.
Publicado: (2013)

Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer’s Disease Neuroimaging (ADNI) database
por: Beltrán, Juan Felipe, et al.
Publicado: (2020)

A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
por: O'Bryant, Sid E., et al.
Publicado: (2011)

Modeling Alzheimer's disease progression utilizing clinical trial and ADNI data to predict longitudinal trajectory of CDR‐SB
por: Jamalian, Samira, et al.
Publicado: (2023)

(18)F-Florbetaben Amyloid PET Imaging: A Chinese Study in Cognitive Normal Controls, Mild Cognitive Impairment, and Alzheimer’s Disease Patients
por: Chang, Yan, et al.
Publicado: (2020)

Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population
por: Dong, Qiu-Yue, et al.
Publicado: (2021)

Comparison of plasma and CSF biomarkers across ethnoracial groups in the ADNI
por: Windon, Charles, et al.
Publicado: (2022)

Computerized cognitive training for Chinese mild cognitive impairment patients: A neuropsychological and fMRI study
por: Li, Bin-Yin, et al.
Publicado: (2019)

Disrupted coupling between salience network segregation and glucose metabolism is associated with cognitive decline in Alzheimer's disease – A simultaneous resting-state FDG-PET/fMRI study
por: Zhang, Miao, et al.
Publicado: (2022)

Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort
por: Risacher, Shannon L, et al.
Publicado: (2009)

Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2019)

Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort
por: Chen, Dandan, et al.
Publicado: (2023)

Predicting Brain Amyloid Using Multivariate Morphometry Statistics, Sparse Coding, and Correntropy: Validation in 1,101 Individuals From the ADNI and OASIS Databases
por: Wu, Jianfeng, et al.
Publicado: (2021)

Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2
por: Edgar, Chris J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5qd8qkdr29l4kdkjsa8fbr8fn